Camillo Ricordi
Overview
Explore the profile of Camillo Ricordi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
361
Citations
10369
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Fotino C, Molano R, Ben Nasr M, Umland O, Fraker C, Ulissi U, et al.
Diabetes
. 2023 Aug;
72(11):1641-1651.
PMID: 37625134
Article Highlights:
12.
Lemos J, Baidal D, Poggioli R, Fuenmayor V, Chavez C, Alvarez A, et al.
Cell Transplant
. 2023 Aug;
32:9636897231166529.
PMID: 37526141
Islet cell transplantation (ITx) is an effective therapeutic approach for selected patients with type 1 diabetes with hypoglycemia unawareness and severe hypoglycemia events. In organ transplantation, human leukocyte antigen (HLA)...
13.
Infante M, Vitiello L, Fabbri A, Ricordi C, Padilla N, Pacifici F, et al.
Immunotherapy
. 2023 Jul;
15(13):1009-1019.
PMID: 37401348
Herein, we describe an unusually prolonged duration (31 months) of the clinical remission phase in a 22-year-old Italian man with new-onset type 1 diabetes. Shortly after the disease diagnosis, the...
14.
Pinheiro M, Pinheiro F, de Arruda M, Beato G, Verde G, Bianchini G, et al.
Arch Endocrinol Metab
. 2023 May;
67(5):e000652.
PMID: 37249465
Objective: The occurrence of partial remission (honeymoon phase) in type 1 diabetes (T1D) has been associated with a reduced risk of chronic microvascular complications of diabetes. We have published case...
15.
Pacifici F, Malatesta G, Mammi C, Pastore D, Marzolla V, Ricordi C, et al.
Cells
. 2023 Mar;
12(5).
PMID: 36899850
: Obesity is a pandemic disease characterized by excessive severe body comorbidities. Reduction in fat accumulation represents a mechanism of prevention, and the replacement of white adipose tissue (WAT) with...
16.
Infante M, Ricordi C
Expert Rev Endocrinol Metab
. 2023 Jan;
18(1):19-32.
PMID: 36692892
Introduction: Diabetes of the exocrine pancreas (DEP; a.k.a. pancreatic diabetes or pancreatogenic diabetes or type 3c diabetes mellitus or T3cDM) refers to different diabetes types resulting from disorders of the...
17.
Paez-Mayorga J, Campa-Carranza J, Capuani S, Hernandez N, Liu H, Chua C, et al.
Nat Commun
. 2022 Dec;
13(1):7951.
PMID: 36572684
Pancreatic islet transplantation efficacy for type 1 diabetes (T1D) management is limited by hypoxia-related graft attrition and need for systemic immunosuppression. To overcome these challenges, we developed the Neovascularized Implantable...
18.
BNT162b2 mRNA COVID-19 Vaccine Does Not Impact the Honeymoon Phase in Type 1 Diabetes: A Case Report
Infante M, Fabbri A, Padilla N, Pacifici F, Di Perna P, Vitiello L, et al.
Vaccines (Basel)
. 2022 Jul;
10(7).
PMID: 35891261
Type 1 diabetes (T1D), which is caused by the autoimmune destruction of insulin-secreting pancreatic beta cells, represents a high-risk category requiring COVID-19 vaccine prioritization. Although COVID-19 vaccination can lead to...
19.
Stock A, Gonzalez G, Pete S, De Toni T, Berman D, Rabassa A, et al.
Sci Adv
. 2022 Jun;
8(26):eabm3145.
PMID: 35767620
Polyethylene glycol (PEG)-based conformal coating (CC) encapsulation of transplanted islets is a promising β cell replacement therapy for the treatment of type 1 diabetes without chronic immunosuppression because it minimizes...
20.
Verhoeff K, Marfil-Garza B, Sandha G, Cooper D, Dajani K, Bigam D, et al.
Transplantation
. 2022 Jun;
106(11):2224-2231.
PMID: 35676866
Background: Preliminary studies show promise for extrahepatic islet transplantation (ITx). However, clinical comparisons with intraportal ITx outcomes remain limited. Methods: This single-center cohort study evaluates patients receiving extrahepatic or intraportal...